Pirfenidone.

Authors
Category Primary study
JournalIDrugs : the investigational drugs journal
Year 2004
Pirfenidone, an antifibrotic tissue growth antagonist, is in development for the potential treatment of fibrotic diseases including renal, liver and pulmonary fibrosis and for multiple sclerosis.
Epistemonikos ID: 1355a463ba33a9e8b040479d987cc23cf54250a8
First added on: Sep 30, 2023